BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20609651)

  • 1. Effect of cardiac resynchronization therapy on cerebral blood flow.
    van Bommel RJ; Marsan NA; Koppen H; Delgado V; Borleffs CJ; Ypenburg C; Bertini M; Schalij MJ; Bax JJ
    Am J Cardiol; 2010 Jul; 106(1):73-7. PubMed ID: 20609651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cardiac resynchronization therapy on left ventricular diastolic filling pattern in responder and nonresponder patients.
    Agacdiken A; Vural A; Ural D; Sahin T; Kozdag G; Kahraman G; Bildirici U; Ural E; Komsuoglu B
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):654-60. PubMed ID: 16008800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of acute changes in left ventricular volume, systolic and diastolic functions, and intraventricular synchronicity after biventricular and right ventricular pacing for heart failure.
    Yu CM; Lin H; Fung WH; Zhang Q; Kong SL; Sanderson JE
    Am Heart J; 2003 May; 145(5):E18. PubMed ID: 12766742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are left ventricular diastolic function and diastolic asynchrony important determinants of response to cardiac resynchronization therapy?
    Yu CM; Zhang Q; Yip GW; Chan YS; Lee PW; Wu LW; Lam YY; Kum LC; Chan HC; Chan S; Fung JW
    Am J Cardiol; 2006 Oct; 98(8):1083-7. PubMed ID: 17027576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality from pump failure and sudden cardiac death in patients with systolic heart failure and left ventricular dyssynchrony: results of the CARE-HF trial.
    Uretsky BF; Thygesen K; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L; Cleland JG
    J Card Fail; 2008 Oct; 14(8):670-5. PubMed ID: 18926439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy in patients with intrinsic and right ventricular pacing-induced left bundle branch block pattern.
    Shen X; Aronow WS; Holmberg MJ; Li H; Nair CK; Korlakunta H; Esterbrooks DJ
    Am J Ther; 2009; 16(6):e44-50. PubMed ID: 19940605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure.
    Zhang Q; Fung JW; Auricchio A; Chan JY; Kum LC; Wu LW; Yu CM
    Eur Heart J; 2006 Jun; 27(12):1423-30. PubMed ID: 16682380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cardiac resynchronization therapy on the mechanisms underlying functional mitral regurgitation in congestive heart failure.
    Porciani MC; Macioce R; Demarchi G; Chiostri M; Musilli N; Cappelli F; Lilli A; Ricciardi G; Padeletti L
    Eur J Echocardiogr; 2006 Jan; 7(1):31-9. PubMed ID: 16378918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy.
    Gradaus R; Stuckenborg V; Löher A; Köbe J; Reinke F; Gunia S; Vahlhaus C; Breithardt G; Bruch C
    Heart; 2008 Aug; 94(8):1026-31. PubMed ID: 17984216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or nonischemic etiology.
    Soliman OI; Theuns DA; ten Cate FJ; Anwar AM; Nemes A; Vletter WB; Jordaens LJ; Geleijnse ML
    Am J Cardiol; 2007 Aug; 100(3):464-9. PubMed ID: 17659930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diastolic asynchrony is more frequent than systolic asynchrony in dilated cardiomyopathy and is less improved by cardiac resynchronization therapy.
    Schuster I; Habib G; Jego C; Thuny F; Avierinos JF; Derumeaux G; Beck L; Medail C; Franceschi F; Renard S; Ferracci A; Lefevre J; Luccioni R; Deharo JC; Djiane P
    J Am Coll Cardiol; 2005 Dec; 46(12):2250-7. PubMed ID: 16360054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy in left ventricular hypertrabeculation/non-compaction and myopathy.
    Stöllberger C; Blazek G; Bucher E; Finsterer J
    Europace; 2008 Jan; 10(1):59-62. PubMed ID: 18029382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
    Sundell J; Engblom E; Koistinen J; Ylitalo A; Naum A; Stolen KQ; Kalliokoski R; Nekolla SG; Airaksinen KE; Bax JJ; Knuuti J
    J Am Coll Cardiol; 2004 Mar; 43(6):1027-33. PubMed ID: 15028362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA; Goktekin O; Kaya MG; Ayhan S; Kucukdurmaz Z; Sutton R; Henein M
    Am J Cardiol; 2009 May; 103(9):1280-4. PubMed ID: 19406272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of stimulation site on diastolic function in cardiac resynchronization therapy.
    de Cock CC; Vos DH; Jessurun E; Allaart CP; Visser CA
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S40-2. PubMed ID: 17302714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.